In February 2025, Gan & Lee Pharmaceuticals (hereafter referred to as "Gan & Lee," stock code: 603087.SH) unveiled that the first participant was successfully dosed in a large-scale Phase 3 clinical trial (OPTIMUM-2) of Bofanglutide, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) independently, in Chinese participant with type 2 diabetes mellitus (T2DM)
However, the glucagon component increases energy expenditure, which theoretically offsets some fatigue
Using amber glass vials, desiccants, and airtight secondary bags are simple but effective safeguards that should not be ignored
The documented failure modes in the compounded GLP-1 category are specific, sourced, and preventable with the right questions asked before enrollment rather than after
Dispose of used pens and needles safely in a sharps bin, which can be obtained from your GP surgery or pharmacy
But knowing the science makes the technique intuitive rather than memorized